fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Aspirin raises bleeding risk marginally among patients with diabetes

Written by | 31 Jul 2012

by Bruce Sylvester – taken from The Journal of the American Medical Association (JAMA) Researchers in a large, retrospective study report that daily use of low-dose aspirin is… read more.

New skin cancer drug cited as therapeutic breakthrough

Written by | 31 Jul 2012

by Bruce Sylvester taken from the New England Journal of Medicine (NEJM) Vismodegib (Erivedge), a new skin cancer drug for advanced basal cell carcinoma, was called “the greatest… read more.

Opioids double risk of death from any cause

Written by | 31 Jul 2012

by Bruce Sylvester – taken from the British Medical Journal (BMJ) Long-term opium use almost doubles the risk of death from many causes, particularly circulatory diseases, respiratory conditions,… read more.

Zinc reduces treatment failure in children with major infections

Written by | 31 Jul 2012

by Bruce Sylvester – taken from The Lancet – Young children with suspected serious bacterial infection treated with zinc and standard antibiotics have achieved a significantly reduced rat… read more.

ASCO 2012 Report – Abiraterone added to pre-surgical regimen helps eliminate prostate tumor in some men with high-risk prostate cancer

Written by | 31 Jul 2012

by Bruce Sylvester – In a randomized Phase II study presented at ASCO, investigators reported that 6 months of treatment with the targeted drug abiraterone (Zytiga) when added… read more.

ASCO 2012 Report – Olanzapine appears to control breakthrough chemotherapy-induced nausea and vomiting

Written by | 31 Jul 2012

by Bruce Sylvester – Investigators from a Phase III trial reported at ASCO that chemotherapy-induced nausea and vomiting (CINV) which is unresponsive to conventional treatments reponds to olanzapine… read more.

ASCO 2012 Report – Combination targeted therapy shows efficacy and fewer toxicities in advanced melanoma treatment

Written by | 31 Jul 2012

by Bruce Sylvester – Results from an expanded Phase IB trial presented at ASCO suggest that combination therapy with two investigational and targeted drugs, BRAF inhibitor dabrafenib and… read more.

ASCO 2012 Report – Combination Lenalidomide (Revlimid)/ Rituximab (Rituxan) improves response rate in patients with relapsed follicular lymphoma

Written by | 31 Jul 2012

by Bruce Sylvester – Investigators reported at ASCO that relapsed follicular lymphoma patinets treated with combination lenalidomide (Revlimid) and rituximab (Rituxan) achieved a higher percentage of overall response… read more.

ASCO 2012 Report – Early, highly promising results for Crizotinib (Xalkori) in three aggressive pediatric cancers

Written by | 31 Jul 2012

by Bruce Sylvester – In a phase I study presented at ASCO, researchers reported that crizotinib (Xalkori) stalled tumor growth and, in some cases, eradicated all signs of… read more.

Vitamin D could help protect lungs in smokers

Written by | 31 Jul 2012

by Bruce Sylvester – Results from a new study suggest that Vitamin D deficiency is related to lung function in smokers, suggesting that vitamin D supplementation could be… read more.

Combination of obesity and low Vitamin D could increase risk of diabetes

Written by | 31 Jul 2012

by Bruce Sylvester – The combination of obesity and low vitamin D deficiency appears to cause a greater risk of insulin resistance than either factor alone, researchers reported… read more.

Child diabetes rates eclipse US

Written by | 31 Jul 2012

by Gary Finnegan – World Health Matters (China) – Child diabetes levels in China are higher than those in the US, according to a startling new study based… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.